이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Supplying Useful Perimenopause Through Post-menopause Online Resources and Tools (SUPPORT)

2026년 5월 11일 업데이트: KDH Research & Communication
The goal of the study is to examine the extent to which exposure to the SUPPORT prototype increases community health workers' (CHWs) knowledge, skills, and self-efficacy to conduct effective outreach to minority women experiencing the menopausal transition. The investigators will collect quantitative, pretest and posttest survey data from adult CHWs.

연구 개요

상세 설명

The investigators will use a randomized, two-group, pretest/posttest design to develop and evaluate the Supplying Useful Perimenopause through Post-menopause Online Resources and Tools (SUPPORT) course and explore the following research question: To what extent does exposure to the SUPPORT prototype increase community health workers' (CHWs) knowledge, skills, and self-efficacy to conduct mental health outreach to minority women experiencing the menopausal transition?

The SUPPORT prototype will have four lessons with text, video vignettes, handouts, and artificial intelligence (AI) avatar simulations. CHWs assigned to the treatment group will be exposed to SUPPORT prototype before completing the posttest while CHWs assigned to the control group will be exposed to the SUPPORT prototype after completing the posttest.

Researchers worked with subject matter experts and the intended audience to ensure the SUPPORT course includes accurate material and reflects the specific needs of CHWs providing outreach to women experiencing the menopausal transition.

Co-Principal Investigators Morgan Fleming (KDH Research & Communication), with input from Co-PI Mary Dolan (Emory University) and the subject matter experts, developed necessary research materials, including the recruitment protocols, evaluation instrumentation, and human subjects consent materials. Co-PI Fleming also outlined the appropriate statistical analysis methods. All procedure documents will be reviewed by the KDH Research & Communication (KDHRC) Institutional Review Board before the evaluation launch.

Investigators will recruit participants by sharing the opportunity through the KDHRC CHW panel, which notifies more than 700 subscribed CHWs about research opportunities. Notifications and flyers will provide information about the goal of the study, participant eligibility, and a link to an eligibility form. Once a potential participant completes the eligibility form and s/he is eligible for the study, they will receive a link to a consent form located on a secure online platform.

The study will include up to 160 CHWs nationwide (80 treatment group, 80 control group). KDHRC will remind participants that participation in the study is completely voluntary.

Investigators will confirm consent for each participant and after confirming consent, will send participants the link to complete the pretest survey. Once the investigators receive the pretest survey, they will randomize each participant into the treatment group or control group using a 1:1 randomization. Investigators will alternate assigning each participant with completed pretest to the treatment groups or the control groups. Then, investigators will provide each participant with group-specific information. Participant responses to pretest and posttest survey measures will be linked using non-personal identifiers.

The investigators will download and export the data from the online survey platform into encrypted Excel files and import the raw data into STATA. The investigators will match the pretest and posttest using the non-personal identifiers and conduct analyses to test for the effect of SUPPORT course exposure on changes in CHWs' knowledge, skills, and self-efficacy.

The initial evaluation criterion is: Statistically significant (p<0.05) and positive relationship between exposure to SUPPORT course and increased knowledge among the treatment group in comparison to the control group.

연구 유형

중재적

등록 (추정된)

160

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Georgia
      • Atlanta, Georgia, 미국, 30309
        • KDH Research & Communication

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

설명

Inclusion Criteria:

  • Must be at least 18 years old.
  • Must self-identify as a community health worker (CHW).
  • Must live in the United States.
  • Must conduct outreach to minority women.
  • Must have six months of field experience. KDHRC defines "field experience" as conducting outreach activities in their community, for example, working with clients in a clinic, conducting home visits, or educating clients at health fairs or community events.
  • Must be an active CHW. KDHRC defines "active" as conducting outreach activities, such as working with clients in a clinic, conducting home visits, or educating clients at health fairs or community events, in the last six months.
  • Must have Internet access either at home or at work to access the materials and/or online surveys

Exclusion Criteria:

  • none

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Treatment: SUPPORT course
Lessons 1-4 of professional development training course for CHWs on menopausal transition (SUPPORT)
Multi-module SUPPORT online training
간섭 없음: Control: No SUPPORT course
No intervention

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Declarative Knowledge Pretest Score
기간: Baseline
Investigators will ask participants multiple-choice knowledge questions related to the menopausal transition, which the investigators will sum to create a composite knowledge score ranging from 0 to 7. A score of 0 means a participant got zero questions correct, while a score of 7 means a participant got all 7 questions correct. Then, the investigators will create the composite knowledge average by dividing the participant's composite score by the total number of questions (7) and multiplying by 100. The higher the score, the more questions a participant answered correctly.
Baseline
Declarative Knowledge Posttest Score
기간: Upon study completion, average 15 days
Investigators will ask participants multiple-choice knowledge questions related to the menopausal transition, which the investigators will sum to create a composite knowledge score ranging from 0 to 7. A score of 0 means a participant got zero questions correct, while a score of 7 means a participant got all 7 questions correct. Then, the investigators will create the composite knowledge average by dividing the participant's composite score by the total number of questions (7) and multiplying by 100. The higher the score, the more questions a participant answered correctly.
Upon study completion, average 15 days
Procedural Knowledge Pretest Score
기간: Baseline
Investigators will ask participants multiple-choice procedural knowledge questions related to the menopausal transition, which the investigators will sum to create a composite procedural knowledge score ranging from 0 to 5. A score of 0 means a participant got zero questions correct, while a score of 5 means a participant got all 5 questions correct. Then, investigators will create the composite procedural knowledge average by dividing the participant's composite score by the total number of questions (5) and multiplying by 100. The higher the score, the more questions a participant answered correctly.
Baseline
Procedural Knowledge Posttest Score
기간: Upon study completion, average 15 days
Investigators will ask participants multiple-choice procedural knowledge questions related to the menopausal transition, which investigators will sum to create a composite procedural knowledge score ranging from 0 to 5. A score of 0 means a participant got zero questions correct, while a score of 5 means a participant got all 5 questions correct. Then, investigators will create the composite procedural knowledge average by dividing the participant's composite score by the total number of questions (5) and multiplying by 100. The higher the score, the more questions a participant answered correctly.
Upon study completion, average 15 days
Skills Pretest Score
기간: Baseline
Investigators will ask all participants Likert-type scale questions about skills to conduct menopausal transition outreach. Each answer choice rating will range from 1 to 10, with higher ratings representing more outreach experience. Investigators will create the composite skills score by summing the scores from the participant's 15 skill items with a range of 15 to 150. Then, investigators will create the composite skills average by dividing the participant's composite score by the total number of questions (15), and the composite score will range from 1 to 10. The higher the score, the more experience a participant indicates.
Baseline
Skills Posttest Score
기간: Upon study completion, average 15 days
Investigators will ask all participants Likert-type scale questions about skills to conduct menopausal transition outreach. Each answer choice rating will range from 1 to 10, with higher ratings representing more outreach experience. Investigators will create the composite skills score by summing the scores from the participant's 15 skill items with a range of 5 to 150. Then, Investigators will create the composite skills average by dividing the participant's composite score by the total number of questions (15), and the composite score will range from 1 to 10. The higher the score, the more experience a participant indicates.
Upon study completion, average 15 days
Self-efficacy Pretest Score
기간: Baseline
Investigators will ask all participants Likert-type scale questions related to perceived self-efficacy with conducting menopausal transition outreach. Each rating will range from 1 to 10, with higher ratings representing higher perceptions of confidence in providing outreach. Investigators will create the composite self-efficacy score by summing the scores from the participant's 5 self-efficacy items with a range of 5 to 50. Then, investigators will create the composite self-efficacy average by dividing the participant's composite score by the number of self-efficacy items (5). The composite will range from 1 to 10.
Baseline
Self-efficacy Posttest Score
기간: Upon study completion, average 15 days
Investigators will ask all participants Likert-type scale questions related to perceived self-efficacy with conducting menopausal transition outreach. Each rating will range from 1 to 10, with higher ratings representing higher perceptions of confidence in providing outreach. Investigators will create the composite self-efficacy score by summing the scores from the participant's 5 self-efficacy items with a range of 5 to 50. Then, investigators will create the composite self-efficacy average by dividing the participant's composite score by the number of self-efficacy items (5). The composite average will range from 1 to 10.
Upon study completion, average 15 days
Intentions Pretest Score
기간: Baseline
Investigators will ask all participants Likert-type scale questions related to intentions of conducting menopausal transition outreach. Each rating will range from 1 to 10, with higher ratings representing higher intentions to provide outreach. Investigators will create the composite intention score by summing the scores from the participant's 4 intention items with a range of 4 to 40. Then, investigators will create the composite intentions average by dividing the participant's composite score by the number of intention items (4). The composite average will range from 1 to 10.
Baseline
Intentions Posttest Score
기간: Upon study completion, average 15 days
Investigators will ask all participants Likert-type scale questions related to intentions of conducting menopausal transition outreach. Each rating will range from 1 to 10, with higher ratings representing higher intentions to provide outreach. Investigators will create the composite intention score by summing the scores from the participant's 4 intentions items with a range of 4 to 40. Then, investigators will create the composite intention average by dividing the participant's composite score by the number of intention items (4). The composite average will range from 1 to 10.
Upon study completion, average 15 days

2차 결과 측정

결과 측정
측정값 설명
기간
Satisfaction at posttest
기간: Upon study completion, average 15 days
Investigators will ask only the treatment group participants Likert-type scale questions related to their satisfaction with the SUPPORT course. Each rating will range from 1 to 10, with higher scores representing higher satisfaction with the SUPPORT prototype. Investigators will sum the scores from the participant's 4 satisfaction items for a satisfaction composite score ranging from 4 to 40. Investigators will then create the satisfaction composite average by dividing by the total number of satisfaction items (4). Scores range from 1 to 10, with higher scores meaning better satisfaction/outcome.
Upon study completion, average 15 days

기타 결과 측정

결과 측정
측정값 설명
기간
Change in Declarative Knowledge Scores From Pretest to Posttest
기간: From baseline through study completion, average 15 days
At both pretest and posttest, investigators created a composite knowledge score for each participant ranging from 0 to 100. A score of 0 means a participant got zero questions correct while a score of 100 means a participant got all questions correct. Investigators will then subtract pretest composite from posttest composite. Higher scores mean higher gains from baseline to posttest.
From baseline through study completion, average 15 days
Change in Procedural Knowledge Scores From Pretest to Posttest
기간: From baseline through study completion, average 15 days
At both pretest and posttest, investigators created a composite procedural knowledge score for each participant ranging from 0 to 100. A score of 0 means a participant got zero questions correct while a score of 100 means a participant got all questions correct. Investigators will then subtract pretest composite from posttest composite. Higher scores mean higher gains from baseline to posttest.
From baseline through study completion, average 15 days
Change in Skills Scores From Pretest to Posttest
기간: From baseline through study completion, average 15 days
At both pretest and posttest, investigators created a composite skills score for each participant ranging from 1 to 10. Higher ratings represent higher perceived experience. Investigators will then subtract pretest composite from posttest composite. Higher scores mean higher gains from baseline to posttest.
From baseline through study completion, average 15 days
Change in Self-efficacy Scores From Pretest to Posttest
기간: From baseline through study completion, average 15 days
At both pretest and posttest, investigators created a composite self-efficacy score for each participant ranging from 1 to 10. Higher ratings represent high perceptions of confidence in providing outreach. Investigators will then subtract pretest composite from posttest composite. Higher scores mean higher gains from baseline to posttest.
From baseline through study completion, average 15 days
Change in Intentions Scores From Pretest to Posttest
기간: From baseline through study completion, average 15 days
At both pretest and posttest, investigators created a composite intentions score for each participant ranging from 1 to 10. Higher ratings represent high intentions in providing outreach. Investigators will then subtract pretest composite from posttest composite. Higher scores mean higher gains from baseline to posttest.
From baseline through study completion, average 15 days

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Morgan Fleming, MPH, KDH Research & Communication

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 3월 6일

기본 완료 (실제)

2026년 4월 2일

연구 완료 (추정된)

2026년 5월 31일

연구 등록 날짜

최초 제출

2026년 4월 17일

QC 기준을 충족하는 최초 제출

2026년 5월 11일

처음 게시됨 (실제)

2026년 5월 15일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 5월 15일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 5월 11일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 2025-05-07
  • 1R43MD018555-01A1 (미국 NIH 보조금/계약)

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다